Premier Alternatives

Hypershell

Robotics · Shanghai, Shanghai · Founded 2021 · Privately Held (backing)

Developer of exoskeleton equipment intended for therapeutic purposes. Hypershell is based in Shanghai, Shanghai and was founded in 2021. Its last reported valuation was $400 million in Nov 2025. It has raised $70.2 million across 1 recorded round; the latest was a $50 million Series B+ in May 2026.

Last reported valuation
$400.0M
Oct 2026
Priced at
—
Total raised
$70.2M
Last round
Series B+
May 2026

Hypershell key facts

as of Oct 2026
  • Developer of exoskeleton equipment intended for therapeutic purposes.
  • Hypershell is valued at approximately $400.0M as of Oct 2026 (last reported valuation).
  • It has raised $70.2M across 1 recorded rounds; the latest was Series B+ ($50.0M) in May 2026.
  • Notable investors include Sequoia Capital, HSG (Hong Kong), Miracleplus, IDG Capital, 5Y Capital — 13 tracked in total.
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$400.0M

Hypershell's last reported valuation, Nov 2025. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Hypershell with a free account
  • ·The complete investor list: 13 names
  • ·Watch Hypershell: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Hypershell funding rounds

1 rounds
May 2026Series B+$50.0M▮
Full funding history →

Hypershell leadership

Hypershell valuation

Hypershell's last reported valuation was $400 million in Nov 2025. No priced round, secondary trade or fund mark has surfaced since.

How much has Hypershell raised?

Hypershell has raised $70.2 million in total; 1 of its rounds is on record. The largest on record was a $50 million Series B+ in May 2026.

Hypershell investors

13 investors are on record for Hypershell, including Sequoia Capital, HSG (Hong Kong), Miracleplus and IDG Capital.

Who runs Hypershell

2 people are listed on the Hypershell team: 2 executives, including Sun Kuan (孙宽) (Founder) and Yu Zhipeng (余志鹏) (Partner).

Comparable companies

Comparable robotics names by valuation on PrivateMarketView: Foundation Robotics Labs ($1.1 billion), Hyphen ($274 million) and AeroVect ($63 million).

About Hypershell

Developer of exoskeleton equipment intended for therapeutic purposes. The company offers exoskeleton products through an optimal exoskeleton solution optimized by simulation technology and artificial intelligence, thereby providing users with innovative and efficient therapeutic equipment.

Industry
Robotics
Sector
Information Technology
HQ
Shanghai, Shanghai, China
Founded
2021
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.